actrapid® flexpen® 100 iuml solution for injection in pre-filled pen
novo nordisk pharma (malaysia) sdn. bhd. - insulin human -
mixtard® 30 flexpen® 100 iuml suspension for injection in pre-filled pen
novo nordisk pharma (malaysia) sdn. bhd. - insulin human -
insulatard® flexpen® 100 iuml suspension for injection in pre-filled pen
novo nordisk pharma (malaysia) sdn. bhd. - insulin (human monocomponent), isophane -
duosulin 30:70 suspension for injection (im/sc)
pnf pharmaceutical, inc.; distributor: duopharma trade phils., inc. - insulin human (dna) - suspension for injection (im/sc) - 100 iu/ml (30% soluble insulin human / 70% isophane insulin human)
inpremzia
baxter holding b.v. - insulin human (rdna) - diabetes mellitus - drugs used in diabetes - inpremzia is indicated for the treatment of diabetes mellitus.
insuljack 30:70 100 iu/ml
n/a; importer: pnf pharmaceutical, inc.; distributor: jackpharma inc. - insulin human (rdna) - suspension for injection (im/sc) (30% soluble insulin human/ 70% isophane insulin human) - 100 iu/ml
prozinc
boehringer ingelheim vetmedica gmbh - insulin human - insulins and analogues for injection, intermediate-acting - cats; dogs - for the treatment of diabetes mellitus in cats and dogs to achieve reduction of hyperglycaemia and improvement of associated clinical signs.
humulin 30/70
eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus
humulin nph
eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus
humulin r
eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] excipient: glycerol hydrochloric acid as 10% solution for ph adjustment metacresol sodium hydroxide as 10% solution for ph adjustment water for injection - humulin is indicated for the treatment of insulin-requiring diabetes mellitus.